Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4574436
Max Phase: Preclinical
Molecular Formula: C19H19ClF2N2O5S
Molecular Weight: 460.89
Molecule Type: Unknown
Associated Items:
ID: ALA4574436
Max Phase: Preclinical
Molecular Formula: C19H19ClF2N2O5S
Molecular Weight: 460.89
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(Nc1ccc(F)c(Cl)c1)c1ccc(F)c(S(=O)(=O)N2C[C@H](O)CC[C@H](O)C2)c1
Standard InChI: InChI=1S/C19H19ClF2N2O5S/c20-15-8-12(2-6-16(15)21)23-19(27)11-1-5-17(22)18(7-11)30(28,29)24-9-13(25)3-4-14(26)10-24/h1-2,5-8,13-14,25-26H,3-4,9-10H2,(H,23,27)/t13-,14+
Standard InChI Key: HOSYNOKQENUKRP-OKILXGFUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 460.89 | Molecular Weight (Monoisotopic): 460.0671 | AlogP: 2.38 | #Rotatable Bonds: 4 |
Polar Surface Area: 106.94 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.40 | CX Basic pKa: | CX LogP: 2.15 | CX LogD: 2.15 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.65 | Np Likeness Score: -1.81 |
1. Kuduk SD, Lam AM, Espiritu C, Vogel R, Lau V, Klumpp K, Flores OA, Hartman GD.. (2019) SAR studies in the sulfonyl carboxamide class of HBV capsid assembly modulators., 29 (16): [PMID:31227344] [10.1016/j.bmcl.2019.05.029] |
2. Kuduk SD,Stoops B,Alexander R,Lam AM,Espiritu C,Vogel R,Lau V,Klumpp K,Flores OA,Hartman GD. (2021) Identification of a new class of HBV capsid assembly modulator., 39 [PMID:33610748] [10.1016/j.bmcl.2021.127848] |
Source(1):